A4i is a collaborative venture between CAMH Centre for Addiction and Mental Health, Canada’s largest mental health teaching hospital, and research centre MEMOTEXT Corp, North America’s leader in machine learning and evidence-based development of precision digital patient engagement.
The digital/clinical team at A4i brings together an optimal skill set for developing and commercializing an industry-leading behavioural health technology in the mental health space. A4i’s robust and proprietary set of technology, with clinically specific IP and significant market access through commercial and clinical collaborative opportunities, is unique as it was designed with both clinical and digital health commercialization expertise from its collaborative parties. 
Our team leverages proven expertise in clinical and digital health to co-commercialize a digital therapeutic intervention to improve the lives of individuals with schizophrenia and other psychoses.